We represent dozens of pharmaceutical, medical device, biotech and healthcare entities across the nation in multidistrict litigations, class actions, Daubert proceedings, and as national discovery counsel related to product liability and toxic torts claims.
Our attorneys address scientific, epidemiologic and complex medical issues in class action and multi-jurisdictional litigation. We draw upon this deep knowledge to design discovery and trial strategies, evaluate related scientific and regulatory concerns, and select and prepare expert witnesses.
Our “molecule to market” program counsels both leading life science companies and innovative start-up ventures on far-reaching decisions related to structuring clinical trials, pursuing in-depth research into ground-breaking medicines and devices, and how best to protect the valuable intellectual property that serves as the foundation for your success. We also provide a comprehensive overview of all legal and regulatory compliance matters associated with informed consent documents and procedures, risk management and avoidance, and pre-trial and post-trial marketing studies.
The firm has played a role in serving as national discovery counsel for numerous pharmaceutical and medical device clients. Our decades of experience handling large-scale document and data productions enable us to assist our clients in complying with the increasing burdens of document and electronic data retention. We routinely advise on records management and ESI issues in small actions and large, complex MDL litigations.